speb/financial-data huggingface dataset:
KRC balance_sheet (quarterly, 2026-03-31) — Common Stock: 1163000.00
KRC cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -64534000.00
KRC balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 5265162000.00
KRC cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -79641000.00
KRC income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 94262000.00
KRC balance_sheet (quarterly, 2026-03-31) — Current Assets: 862417000.00
KRC balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 201910000.00
KRC balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 201910000.00
KRC balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 569139000.00
KRC cash_flow (quarterly, 2026-03-31) — Depreciation: 94626000.00
KRC cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 94626000.00
KRC income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 94344000.00
KRC cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 94626000.00
KRC income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 94344000.00
KRC income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 117637000.00
KRC income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.16
KRC income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -19214000.00
KRC balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 63421000.00
KRC income_statement (quarterly, 2026-03-31) — EBIT: 23838000.00
KRC income_statement (quarterly, 2026-03-31) — EBITDA: 118464000.00
KRC cash_flow (quarterly, 2026-03-31) — End Cash Position: 192904000.00
KRC cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -152155000.00
KRC cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 18103000.00
KRC cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -23525000.00
KRC income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: 23525000.00
KRC income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 20699000.00
KRC balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 16043000.00
KRC balance_sheet (quarterly, 2026-03-31) — Gross PPE: 186788000.00
KRC income_statement (quarterly, 2026-03-31) — Gross Profit: 175791000.00
KRC income_statement (quarterly, 2026-03-31) — Impairment Of Capital Assets: 61778000.00
KRC income_statement (quarterly, 2026-03-31) — Interest Expense: 38511000.00
KRC income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 38511000.00
KRC income_statement (quarterly, 2026-03-31) — Interest Income: 954000.00
KRC income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 954000.00
KRC cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 30584000.00
KRC balance_sheet (quarterly, 2026-03-31) — Invested Capital: 9854553000.00
KRC cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 15048000.00
KRC balance_sheet (quarterly, 2026-03-31) — Investment Properties: 9469314000.00
KRC balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 127414000.00
KRC balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 4589391000.00
KRC balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 4716805000.00
KRC cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -1600000.00
KRC balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 58954000.00
KRC balance_sheet (quarterly, 2026-03-31) — Minority Interest: 223752000.00
KRC income_statement (quarterly, 2026-03-31) — Minority Interests: -4594000.00
KRC cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 141440000.00
KRC cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -79641000.00
KRC balance_sheet (quarterly, 2026-03-31) — Net Debt: 4396487000.00
KRC income_statement (quarterly, 2026-03-31) — Net Income: -19267000.00
KRC income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -19214000.00
KRC income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -14673000.00
KRC income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -19267000.00
KRC income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -19267000.00
KRC cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -14673000.00
KRC income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -14673000.00
KRC income_statement (quarterly, 2026-03-31) — Net Interest Income: -37557000.00
KRC cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -1600000.00
KRC cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -1600000.00
KRC income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -37557000.00
KRC cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -6380000.00
KRC cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 6200000.00
KRC balance_sheet (quarterly, 2026-03-31) — Net PPE: 154488000.00
KRC balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 5265162000.00
KRC balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 279477000.00
KRC income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 156717000.00
KRC income_statement (quarterly, 2026-03-31) — Normalized Income: 18986000.00
KRC cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 150695000.00
KRC cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -23525000.00
KRC income_statement (quarterly, 2026-03-31) — Operating Income: 60748000.00
KRC income_statement (quarterly, 2026-03-31) — Operating Revenue: 270791000.00
KRC balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 116278807.00
KRC income_statement (quarterly, 2026-03-31) — Other Gand A: 20699000.00
KRC income_statement (quarterly, 2026-03-31) — Other Income Expense: -37864000.00
KRC cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -2898000.00
KRC balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 9162000.00
KRC income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 389000.00
KRC balance_sheet (quarterly, 2026-03-31) — Other Properties: 127834000.00
KRC balance_sheet (quarterly, 2026-03-31) — Other Receivables: 425420000.00
KRC balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 31417000.00
KRC income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: -53000.00
KRC balance_sheet (quarterly, 2026-03-31) — Payables: 367229000.00
KRC balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 367229000.00
KRC balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 8193000.00
KRC income_statement (quarterly, 2026-03-31) — Pretax Income: -14673000.00
KRC cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 358000.00
KRC balance_sheet (quarterly, 2026-03-31) — Receivables: 441132000.00
KRC income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 93980000.00
KRC income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 94626000.00
KRC income_statement (quarterly, 2026-03-31) — Rent Expense Supplemental: 6197000.00
KRC cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -1600000.00
KRC cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -79641000.00
KRC balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 102859000.00
KRC cash_flow (quarterly, 2026-03-31) — Sale Of Business: 141440000.00
KRC income_statement (quarterly, 2026-03-31) — Selling General And Administration: 20699000.00
KRC balance_sheet (quarterly, 2026-03-31) — Share Issued: 116278807.00
KRC income_statement (quarterly, 2026-03-31) — Special Income Charges: -38253000.00
KRC cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 4869000.00
KRC balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 5265162000.00
KRC balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 5265162000.00
KRC income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
KRC income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
KRC balance_sheet (quarterly, 2026-03-31) — Total Assets: 10774858000.00
KRC balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 9854553000.00
KRC balance_sheet (quarterly, 2026-03-31) — Total Debt: 4716805000.00
KRC balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 5488914000.00
KRC income_statement (quarterly, 2026-03-31) — Total Expenses: 209305000.00
KRC balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 5285944000.00
KRC balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 9912441000.00
KRC balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 4716805000.00
KRC income_statement (quarterly, 2026-03-31) — Total Unusual Items: -38253000.00
KRC income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -38253000.00
KRC balance_sheet (quarterly, 2026-03-31) — Working Capital: 293278000.00
KREBSBIO.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -1474484000.00
KREBSBIO.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 1180176000.00
KREBSBIO.NS income_statement (annual, 2022-03-31) — Amortization: 6386000.00
KREBSBIO.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 6386000.00
KREBSBIO.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 21560586.00
KREBSBIO.NS income_statement (annual, 2022-03-31) — Basic EPS: -20.81
KREBSBIO.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 256920000.00
KREBSBIO.NS balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 450000000.00
KREBSBIO.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 324000.00
KREBSBIO.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 21560586.00
KREBSBIO.NS income_statement (annual, 2022-03-31) — Diluted EPS: -20.81
KREBSBIO.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 16487000.00
KREBSBIO.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 11384000.00
KREBSBIO.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 8765000.00
KREBSBIO.NS income_statement (annual, 2022-03-31) — Interest Income: 3578000.00
KREBSBIO.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 3578000.00
KREBSBIO.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 484187000.00
KREBSBIO.NS balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 450000000.00
KREBSBIO.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 1905883000.00
KREBSBIO.NS cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 125130000.00
KREBSBIO.NS income_statement (annual, 2022-03-31) — Net Income Discontinuous Operations: 0.00
KREBSBIO.NS cash_flow (annual, 2022-03-31) — Net Other Financing Charges: 1000.00
KREBSBIO.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 26336000.00
KREBSBIO.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 35120000.00
KREBSBIO.NS balance_sheet (annual, 2022-03-31) — Other Inventories: -1000.00
KREBSBIO.NS balance_sheet (annual, 2022-03-31) — Other Payable: 123747000.00
KREBSBIO.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 969000.00
KREBSBIO.NS income_statement (annual, 2022-03-31) — Other Special Charges: 1791000.00
KREBSBIO.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 11653000.00
KREBSBIO.NS balance_sheet (annual, 2022-03-31) — Preferred Securities Outside Stock Equity: 1300000000.00
KREBSBIO.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 88567000.00
KREBSBIO.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
KREBSBIO.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 119934000.00
KREBSBIO.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 6807000.00
KREBSBIO.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 6807000.00
KREBSBIO.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 683000.00
KREBSBIO.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: -2261160000.00
KREBSBIO.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 38000.00
KREBSBIO.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 11384000.00
KREBSBIO.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 64000.00
KREBSBIO.NS balance_sheet (annual, 2022-03-31) — Tradeand Other Payables Non Current: 62713000.00
KREBSBIO.NS balance_sheet (annual, 2022-03-31) — Work In Process: 119206000.00
KREBSBIO.NS income_statement (annual, 2022-03-31) — Write Off: 0.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — +Operating Expense: 317217000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — +Total Revenue: 521344000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 152806000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 5252000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -1537529000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 1180176000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Amortization: 1839000.00
KREBSBIO.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 1839000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 21560586.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Basic EPS: -11.30
KREBSBIO.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 1006000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 266373000.00
KREBSBIO.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -108704000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 450000000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 215606000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 175000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 175000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 175000.00
KREBSBIO.NS cash_flow (annual, 2023-03-31) — Change In Inventory: 136170000.00
KREBSBIO.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 51527000.00
KREBSBIO.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -64303000.00
KREBSBIO.NS cash_flow (annual, 2023-03-31) — Change In Payable: -226258000.00
KREBSBIO.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 3513000.00
KREBSBIO.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -98383000.00
KREBSBIO.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -149000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Common Stock: 215606000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: -994623000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 25782000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 423518000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Current Assets: 160609000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Current Debt: 101239000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 101239000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 491047000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 7467000.00
KREBSBIO.NS cash_flow (annual, 2023-03-31) — Depreciation: 63746000.00
KREBSBIO.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 65585000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 65585000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 63746000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 21560586.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Diluted EPS: -11.30
KREBSBIO.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -246919000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — EBIT: -217209000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — EBITDA: -151624000.00
KREBSBIO.NS cash_flow (annual, 2023-03-31) — End Cash Position: 858000.00
KREBSBIO.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 373433000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 13129000.00
KREBSBIO.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -355836000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 8598000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 26870000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 3027997000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Gross Profit: 97826000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Interest Expense: 29710000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 29710000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Interest Income: 2203000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 2203000.00
KREBSBIO.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -29732000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Inventory: 119456000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 839081000.00
KREBSBIO.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -126450000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 23756000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 484187000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 450000000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 1732465000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 2182465000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 3066000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 2037336000.00
KREBSBIO.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 0.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Net Debt: 1833529000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Net Income: -246919000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -246919000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -246919000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -246919000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -246919000.00
KREBSBIO.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: -246919000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -246919000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Net Interest Income: -27529000.00
KREBSBIO.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 403165000.00
KREBSBIO.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 403165000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -27529000.00
KREBSBIO.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -17746000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Net PPE: 1490468000.00
KREBSBIO.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -108704000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: -1021493000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 25962000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 35889000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: -151624000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Normalized Income: -246919000.00
KREBSBIO.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: -247132000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Operating Income: -219391000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Operating Revenue: 521344000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 21560586.00
KREBSBIO.NS cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: -1000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 122929000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 3938000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 26870000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Other Inventories: -1000.00
KREBSBIO.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 29732000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: -3000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: -1000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 6201000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 48810000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Other Payable: 101452000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Other Properties: 214319000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 2622000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 2859000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Payables: 254258000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 12621000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 32422000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Pretax Income: -246919000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
KREBSBIO.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 2854000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 42474000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 423518000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 65585000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 6879000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 6879000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 683000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: -2504851000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 8598000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Share Issued: 21560586.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Special Income Charges: 0.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: -994623000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: -1021493000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Tax Provision: 0.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Total Assets: 1749817000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 737842000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Total Debt: 2283704000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: -994623000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Total Expenses: 740735000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 2744440000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 1589208000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 2253393000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 22000.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 0.00
KREBSBIO.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 0.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Tradeand Other Payables Non Current: 44967000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Work In Process: 63854000.00
KREBSBIO.NS balance_sheet (annual, 2023-03-31) — Working Capital: -330438000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — +Operating Expense: 344684000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — +Total Revenue: 504215000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 189700000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 19034000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -1603355000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 1180176000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Amortization: 1838000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 1839000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 21560586.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Basic EPS: -9.15
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 858000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 273022000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -94150000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 450000000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 215606000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 691000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 691000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 691000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Change In Inventory: 21492000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -33517000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 93010000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Change In Payable: 36894000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -13782000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: 102095000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 514000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Common Stock: 215606000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: -1192167000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 4385000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 311488000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Current Assets: 174422000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Current Debt: 101760000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 101760000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 618339000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 6192000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Depreciation: 65825000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 67664000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 67663000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 65825000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 21560586.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Diluted EPS: -9.15
KREBSBIO.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: -197284000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — EBIT: -150425000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — EBITDA: -82761000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — End Cash Position: 1374000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 55032000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 15110000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -70501000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 0.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 6001000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 25032000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 3100749000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Gross Profit: 192727000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Interest Expense: 46859000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 46859000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Interest Income: 1567000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 1567000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -46894000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Interest Paid Cfo: 0.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Inventory: 97964000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 744593000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -78167000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 25408000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 484187000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 450000000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 1835000000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 2285000000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 4941000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 2120611000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 0.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Net Debt: 1936069000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Net Income: -197284000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: -197284000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: -197284000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Net Income Discontinuous Operations: 0.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: -197284000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: -197284000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: -197284000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: -197284000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Net Interest Income: -45327000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 101926000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 102535000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -45327000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: -4894000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Net PPE: 1497394000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -73273000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: -609000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: -1217199000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 30502000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 37541000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: -82761000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Normalized Income: -197284000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 23649000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Operating Income: -151957000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Operating Revenue: 504215000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 21560586.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Other Cash Adjustment Outside Changein Cash: 2000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 25921000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 178666000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 3938000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 25032000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 46894000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: -4000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 450000000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 4513000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 58981000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Other Payable: 137594000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Other Properties: 218544000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 29911000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 30129000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Payables: 327294000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 10619000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 26139000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Pretax Income: -197284000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 4280000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -94150000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 31674000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 311488000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 67664000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 5788000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 5788000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 683000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: -2702395000.00
KREBSBIO.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 20877000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 6001000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Share Issued: 21560586.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Special Income Charges: 0.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: -1192167000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: -1217199000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Tax Provision: 0.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Total Assets: 1781747000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 642833000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Total Debt: 2386760000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: -1192167000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Total Expenses: 656172000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 2973914000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 1607325000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 2355575000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 35000.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 0.00
KREBSBIO.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 0.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Tradeand Other Payables Non Current: 40073000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Work In Process: 51180000.00
KREBSBIO.NS balance_sheet (annual, 2024-03-31) — Working Capital: -443917000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 174522000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 25654000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 215606000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 1442000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 112055000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 215606000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: -1301488000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 6586000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 262073000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 436682000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 436682000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 1037132000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 17060000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 24110000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 1471859000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 77267000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 744194000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 26433000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 1609000000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 1609000000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 30502000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 2044240000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 1471859000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: -1325598000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 21560586.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 47097000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 258831000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: -1517094000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 24110000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 67574000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 450000000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 1465273000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 110613000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Payables: 174522000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 21560586.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: -1301488000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: -1325598000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 1852049000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 307512000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 2045682000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: -1301488000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 3153537000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 1589976000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 2116405000.00
KREBSBIO.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: -775059000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — +Operating Expense: 594751000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 125101000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — +Total Revenue: 433119000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 61000000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 181525000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 181525000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 500000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 500000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -1660540000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -1660540000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 1180176000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1180176000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Amortization: 1839000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 1839000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 21568695.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 21588512.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Basic EPS: -12.49
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Basic EPS: -3.83
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 1374000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 275002000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 275002000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -35632000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 450000000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 450000000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 215606000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 215606000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 234000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 234000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 234000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 234000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 234000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 234000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Change In Inventory: 37649000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: 3576000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 17531000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Change In Payable: -8175000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 18534000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: 66392000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 42000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Common Stock: 215606000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 215606000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: -1462388000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -1462388000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 15368000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 15368000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 55557000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 5670000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Current Assets: 102591000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 102591000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Current Debt: 509584000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 509584000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 509584000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 509584000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 1035261000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1035261000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 7896000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 7896000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Depreciation: 66892000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 66892000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 66892000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 15690000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 66892000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 15690000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 21568695.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 21588512.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Diluted EPS: -12.49
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: -3.83
KREBSBIO.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: -269393000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -82684000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — EBIT: -210098000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — EBIT: -66384000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — EBITDA: -143206000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — EBITDA: -50694000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — End Cash Position: 1416000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 128648000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 594000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 594000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -114542000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -1221000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 9402000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 23193000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 23193000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 3128237000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 3128237000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Gross Profit: 377562000.00